TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,646,000 | +128.4% | 48,452 | -18.5% | 0.99% | +138.9% |
| Q1 2022 | $1,596,000 | -28.0% | 59,452 | +28.0% | 0.42% | -25.3% |
| Q4 2021 | $2,216,000 | -20.5% | 46,452 | +10.7% | 0.56% | -24.6% |
| Q3 2021 | $2,787,000 | -25.3% | 41,952 | -12.3% | 0.74% | -5.4% |
| Q2 2021 | $3,733,000 | +275.6% | 47,852 | +355.3% | 0.78% | +230.9% |
| Q1 2021 | $994,000 | -33.7% | 10,509 | -54.7% | 0.24% | -45.5% |
| Q2 2020 | $1,499,000 | -28.4% | 23,210 | -50.5% | 0.43% | -50.5% |
| Q1 2020 | $2,095,000 | +10.6% | 46,908 | +54.3% | 0.87% | +34.5% |
| Q4 2019 | $1,894,000 | +6.5% | 30,408 | -35.7% | 0.65% | -2.8% |
| Q3 2019 | $1,779,000 | – | 47,308 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |